Agilent showcases next‑generation automated solutions at SLAS2026
6 Feb 2026
Agilent Technologies has announced that it will present a range of next‑generation automated workflow innovations at the SLAS2026 International Conference & Exhibition, taking place February 7–11 in Boston, Massachusetts. Agilent will demonstrate how its expanding automation ecosystem — integrating advanced imaging, software, robotics, and AI‑powered optimization — supports laboratories in accelerating discovery with confidence, efficiency, and superior data quality.
At booth #1808, visitors will see examples of Agilent instrumentation integrated into multi‑vendor automated environments — including systems developed with ABB Robotics, HighRes Biosolutions, Biosero, and Unite Labs.
The showcase includes a preview of the upcoming addition to the Cytation imaging family. Designed with enhanced imaging optics and faster, more efficient data acquisition, the new platform advances high‑content imaging capabilities for research and screening applications.
Agilent will also debut the ProteoAnalyzer Software Security Module, a compliance‑enabling software enhancement that helps pharmaceutical and biopharmaceutical manufacturing labs meet stringent global regulatory requirements, including 21 CFR Part 11 and Annex 11.
The module adds secure user authentication, detailed audit trails, permission controls, and electronic signatures to strengthen data integrity and audit readiness across regulated workflows.
Agilent will feature new AI‑driven lab optimization tools integrated into its CrossLab Connect platform, enabled by Sigsense intelligent monitoring technology. This enhancement provides real‑time performance insights, asset‑utilization analytics, and predictive alerts to help laboratories reduce downtime and enhance operational productivity.
Plus, attendees will see continued progress across automation‑ready workflows, including new Bravo liquid‑handling protocols such as GLP‑1 agonist sample preparation.
Agilent will also host two Exhibitor Tutorial Sessions: 'Towards the Digital and Automated Lab,' presented by Anneke Muehlebach, Product Marketing Director in Agilent’s Software Informatics Division, and 'Utilizing High‑Throughput AssayMAP Bravo for Drug Stability, PK, and Immunogenicity Assessment,' led by Nadia Sultana, Senior Scientist at AbbVie.
A Solutions Spotlight Presentation: 'The Next Generation of Hybrid Analysis: Expanding Possibilities in Automated Cell Imaging and Detection' will be held highlighting the Agilent BioTek Cytation platform presented by Bikram Chakraborty, Director of Product Management, Agilent Technologies-BioTek and Seahorse product lines, Agilent.
Additionally, Agilent will participate in a roundtable discussion entitled, 'From Insight to Impact: AI, Robotics and the Convergence toward the Lab of the Future' hosted by ABB Robotics.
